News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Alex Keown

news@biospace.com

BioSpace News - By Alex Keown
The End of the Road: New Jersey's NovaDel Pharma (NVD) to Dissolve 2/23/2017
The 5 Drug Giants That Could Snap Up a Struggling Bristol-Myers Squibb (BMY) 2/23/2017
Backed by Johnson & Johnson (JNJ), Fusion Pharma Launches With $25 Million 2/23/2017
Why This UC Berkeley Scientist is Planning to Take on Washington in 2018 2/22/2017
Serial Investor Carl Icahn Takes Stake in Bristol-Myers Squibb (BMY), Stock Jumps 2/22/2017
North Korean Biotech Institute Allegedly Involved in the Killing of Leader Kim Jong-Un's Half Brother 2/22/2017
Pfizer (PFE), Celgene (CELG), Eli Lilly (LLY), Merck & Co. (MRK) CEOs and Other Execs Send Letter Supporting GOP Tax Plan 2/22/2017
Rumored Acquisition Target Bristol-Myers Squibb (BMY) Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback 2/21/2017
Meet the Professor Who Was the First to Question Theranos' Research 2/21/2017
Zoning Changes Kills Sale of Bristol-Myers Squibb (BMY)'s Connecticut Campus 2/21/2017
What This Contender for FDA's Top Job Could Do His First 6 Months on the Gig 2/21/2017
Why Startup Cue BioPharma Picked Daniel Passeri as Its New CEO 2/21/2017
How Much Money Embattled Theranos Has Left in the Bank 2/21/2017
Norwegian Biotech Upstart Has Become a Potential Takeover Target 2/21/2017
Swiss Biotech Santhera (SANN.SW) Opens Up 20 Employee Shop in Massachusetts, Has Plans to Grow 2/20/2017
Questions Arise Over a Congressman's Ties With Australian Biotech Innate Immunotherapeutics 2/20/2017
3 Biotechs With the Biggest and Most Promising Pipelines 2/20/2017
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial 2/20/2017
Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech 2/20/2017
AMAG (AMAG) to Hire 150 New Sales Reps to Support New Drug Intrarosa 2/17/2017
Another Drug Bites the Dust: Merck & Co. (MRK) Stops Late-Stage Alzheimer’s Study 2/16/2017
ArmaGen CEO: Phase II Data Shows Cognitive Improvement in Juvenile Hurler Syndrome Patients 2/16/2017
Bristol-Myers Squibb (BMY) May Be on the Market, But Pfizer (PFE) Probably Won't Bite 2/16/2017
Questions Remain Over Suicide Death of Genentech (RHHBY) Lobbyist 2/16/2017
Bristol-Myers Squibb (BMY) Could Finally Go on the Market; Rumored Suitors Include Gilead (GILD), Pfizer (PFE), Novartis AG (NVS) and Roche (RHHBY) 2/16/2017
This is Why the Decision on Who Invented CRISPR Matters 2/16/2017
First Ariad (ARIA), Now Senator Bernie Sanders Puts This Drug Company on Notice 2/16/2017
Ipsen (IPN.PA) Agrees to Hire 100 Merrimack (MACK) Employees Under $575 Million Cancer Deal 2/15/2017
Former Celgene (CELG) and Medtronic (MDT) CEOs Just Acquired This Maryland Biotech 2/15/2017
Roche (RHHBY) Faces Off With Itself for $9 Billion Breast Cancer Drug Business 2/15/2017
2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force 2/15/2017
Struggling Teva (TEVA) Mulls Over Sale, Spinoff of Branded Generics Biz 2/14/2017
Eli Lilly (LLY) Quells Rumors Regarding Multi-Million Irish Expansion Plan 2/14/2017
Oops, They Did it Again: Theranos Failed to Inform Patients of Potentially Botched Diabetes Test 2/14/2017
Why Immunomedics (IMMU)' $2 Billion Deal With Seattle Genetics (SGEN) Has venBio Ticked Off and Red-Faced 2/13/2017
Seattle Genetics (SGEN), Immunomedics (IMMU) Ink $2 Billion Tumor Drug Deal 2/13/2017
Why Intercept Pharma (ICPT) Stock Jumped Nearly 10% On Friday After Providing Phase III Update 2/13/2017
Tom Price Confirmed as Donald Trump's Health Chief, But Stock Deals Still Raise Questions 2/10/2017
Aurobindo (AUROPHARMA.BO) Eyes U.S. Plant in New Jersey As Trump Calls for Local Drug Production 2/10/2017
New Alewife Research Center to Attract Spillover Demand From Biotechs Unable to Find Space in Kendall Square 2/10/2017
Biotech Director at Cambridge's Merrimack (MACK) Arrested for Insider Trading Scheme 2/10/2017
This 20-Employee Kendall Square Biotech Just Secured a Seat on Elon Musk's Upcoming Space Rocket 2/10/2017
This Could be Biogen (BIIB)'s Next $1 Billion Blockbuster 2/10/2017
Acorda (ACOR) Rockets After Parkinson's Drug Hits Late-Stage Goals 2/10/2017
Reckitt Benckiser (RB.L) to Lay Off 140 Employees in Missouri 2/9/2017
Pfizer (PFE) to Kiss Its Adelaide Operations Goodbye in 2021, Putting 89 Jobs on the Line 2/9/2017
Sinking Teva (TEVA) Needs a New CEO But May Need to Up Salary 2/9/2017
H. Lundbeck A/S (LUN.CO) Throws in the Towel on Alzheimer's Pill, Giving Leeway to Rival Axovant (AXON) 2/8/2017
LabCorp (LH) Makes $8 Billion+ Proposal to CRO PPD (PPDI) 2/8/2017
Eli Lilly (LLY) Seeks "Voluntary Exits" From 200 Researchers 2/8/2017
Teva (TEVA) CEO Abruptly Steps Down, Ex-Celgene (CELG) Boss Named Chairman of the Board 2/8/2017
Biotech Execs are Hoping Trump Will Pick This Man to Head the FDA 2/7/2017
No Looking Back: Cellectis (CLLS) Preps for Cutting-Edge 'Off-the-Shelf' CAR-T Trial 2/7/2017
GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected 2/7/2017
GlaxoSmithKline (GSK)'s Incoming CEO Preps for Deals, R&D Decisions on New Drugs 2/7/2017
A Look at the Types of Jobs Amgen (AMGN)'s Promise to Trump Will Bring 2/7/2017
31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant (AXON) 2/6/2017
This Can Be Patheon (PTHN)'s Fate in Trump's Call for Increased Drug Production 2/6/2017
Why This Big Biotech Could be Biogen (BIIB)'s Downfall 2/3/2017
Amgen (AMGN) CEO Tells Trump the Company Plans to Hire 1,600 Employees This Year 2/3/2017
What Went Down in Trump's Meeting With Biotech Execs From Amgen (AMGN), Celgene (CELG) and Merck & Co. (MRK) 2/3/2017
Pfizer (PFE) Turns to JPMorgan to Explore $2 Billion Sale of Certain Assets 2/3/2017
Eli Lilly (LLY) Washes Its Hands of Another Phase 3 Study After the Failure of Solanezumab 2/2/2017
AstraZeneca PLC (AZN) Investors Nervous as Its Recovery Hinges on the Success of New Meds and Key Drug Data 2/2/2017
Bay Area's Galena Biopharma  (GALE) CEO Steps Down, Effective Immediately 2/2/2017
Vividion Therapeutics Launches With $50 Million and a Celgene (CELG) Alum as Executive Chairman 2/2/2017
Bay Area Biotech Employees May Soon Get a New Perk—Affordable Housing 2/1/2017
Meet This Largely Over-Looked Phase 3 Alzheimer's Company 2/1/2017
Cambridge's Dimension Therapeutics (DMTX) Tanks to a New Low After Revealing Interim Hemophilia B Data 2/1/2017
Trump to Have Face-to-Face Meeting With Novartis AG (NVS) CEO, Other Pharma Bosses Today 1/31/2017
Bay Area Biotech CEOs React to Trump's Travel Ban 1/31/2017
How Trump's Immigration Ban is Already Hurting Science 1/31/2017
Bay Area's Calithera Biosciences (CALA) Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte (INCY) 1/31/2017
How Bristol-Myers Squibb (BMY) Went From Potential Mega-Acquirer to Vulnerable Mega-Target 1/31/2017
This Pharma Giant Just Revealed 7 Years of Its U.S. Drug Price Increase History 1/30/2017
FDA Lashes Out at Jazz Pharma (JAZZ) CMO for Continued Regulatory Violations 1/30/2017
These 2 New Drugs Make Celgene (CELG) an Even Bigger Biotech Powerhouse 1/30/2017
Cambridge Biotech Jounce (JNCE) Bounces on the IPO Scene, Raises $102 Million 1/27/2017
Incyte (INCY) Who? Why This Biotech Would Give Gilead (GILD) a Bang for Its Buck 1/27/2017
How Trump's Federal Hiring Freeze Impacts Biotech and an Already Short-Staffed FDA 1/27/2017
Investment Firm Pumps $800 Million Into Google (GOOG)'s Verily 1/26/2017
Endo International (ENDP) Eliminates 90 Jobs in Restructuring 1/26/2017
Booming Illumina (ILMN) Expands With a Spanking New Building in San Diego, Hiring More Than 100 1/26/2017
The Rise and Fall of Cambridge Biotech Startup Gen9 1/26/2017
Why Pfizer (PFE) Could be Johnson & Johnson (JNJ)'s Biggest Headache in 2017 1/25/2017
New Frontrunner Emerges for Top FDA Job 1/25/2017
Women Scientists Call on President Trump in Open Letter 1/25/2017
Trump's Controversial Education Nominee Betsy DeVos Also Linked to Theranos 1/24/2017
Two Former AllCells Employees Allegedly Took Confidential Info to Launch Cepheus Biosciences 1/24/2017
485 Eli Lilly (LLY) Employees Will be Out of Work Beginning March 31 1/23/2017
Earnings Preview: Here's a Look at What to Expect From 7 Biopharmas 1/23/2017
Martin Shkreli's Complaint Leads to a $100 Million FTC Settlement for This Biotech 1/20/2017
Merck & Co. (MRK) Expands Discovery to New South San Francisco Facility in Heart of Bay Area and Looks to Hire 100 Employees 1/20/2017
Struggling MannKind (MNKD)'s New Strategy Includes Doubling Its Sales Force 1/19/2017
Sanofi (SNY) Exec Jumps Ship to Helm Merrimack (MACK) 1/19/2017
Theranos Shuts Down Last Remaining Blood-Testing Lab After Another Failed Inspection 1/19/2017
Embattled Theranos Forms New Advisory Board of Biotech Experts 1/18/2017
ImmunoGen (IMGN) CEO Sees Potential in Company’s Lead ADC Product 1/18/2017
Tiny Ovid Inks a Unique Rare Disease Deal With Drug Giant Takeda (TKPYY) 1/18/2017
Why Bristol-Myers Squibb (BMY) Could be a Takeover Target Soon 1/18/2017
Why the Government Should Pay $156 Billion to Own Gilead (GILD) 1/18/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome 1/18/2017
Silicon Valley Exec Meets Trump for FDA Job 1/17/2017
NantKwest CEO (AKA World's Richest Doctor) Rumored to Have Met Trump for Top NIH Job 1/17/2017
Struggling OvaScience (OVAS) Offers CFO Cash to Stay on Board 1/17/2017
MiMedx CEO Allegedly Demanded Employees Donate Cash to Support GOP Candidates Like Tom Price 1/17/2017
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse 1/16/2017
Trump's HHS Nominee and His Ties With Two Massachusetts Biotech Firms 1/16/2017
Trump Says Pharma Getting Away With Murder, Vows to Lower Drug Prices 1/13/2017
Tesaro (TSRO) Craters as the FDA Denies Approval of Rolapitant IV 1/13/2017
And It Gets Worse...Arizona Planning to Sue Theranos Over Faulty Blood Tests 1/13/2017
Gilead (GILD): To Split or Not to Split... 1/13/2017
JPM17: Opko Health (OPK) CEO's Gameplan After Its Recent Growth Hormone Failure 1/13/2017
Merck KGaA (MKGAF.PK) Lays Off Some Employees in Shutdown of Its Massachusetts Accounting Office 1/12/2017
Trump Has Another Top FDA Post to Fill 1/12/2017
JPM17: New Biogen (BIIB) CEO on Groundbreaking Alzheimer's Trial and the Company's Future 1/12/2017
Florida-Based Wearable Device Maker ActiGraph Surges Into 2017 With Big Data Sleep Tech 1/12/2017
Cosmetic Giant L'Oreal Pays $1.3 Billion for Three Skincare Brands From Valeant (VRX) 1/11/2017
JPM17: Eli Lilly (LLY) Not Looking for a Mega-Merger But Stays Open to Other M&A Deals 1/11/2017
Debt-Ridden Valeant (VRX) Offloads Dendreon (DNDN) for $819.9 Million Cash 1/11/2017
Pharma Bro Martin Shkreli's Twitter Account Suspended After Harassing Journalist 1/10/2017
Trump's Defense Pick Officially Cuts Ties With Theranos 1/10/2017
Troubled Theranos Pink Slips Another 41% of Workforce 1/10/2017
Bay Area Genetic Testing Firm Counsyl Lays Off Oncology Sales Team 1/9/2017
Former Biogen (BIIB) CEO to Helm Newly Launched Bay Area Startup Vir Biotechnology 1/9/2017
JPM17: Boardroom Ready Program Prepares 20 Women for Spots on Biotech Corporate Boards 1/9/2017
JPM17: One Year after ‘The Party,’ Michael Rice, LifeSci Advisors Spearhead Gender Diversity in Life Sciences 1/9/2017
JPM17: Prophase CEO Joins Boardroom Ready Program to Take Next Career Step 1/9/2017
JPM17: OncoGenex (OGXI) CMO Cindy Jacobs Looks to WIB Boardroom Ready Program to Reach Goal 1/9/2017
JPM17: A First: Women in Bio’s Cynthia Smith Tapped for Nivalis (NVLS) Board 1/9/2017
JPM17: A Year Later, Alison Arter Sees Progress with Women in Bio Boardroom Ready Program 1/9/2017
Here’s What You Need to Know About Biotech and Pharma to Land a Job in 2017 1/9/2017
SoCal's Ionis Pharma (IONS) Stock Jolted by $1.6 Billion Cardio Drug Deal With This Big Pharma 1/6/2017
Amgen (AMGN) Shares Soar After Blocking Rivals From Selling Competing Cholesterol-Lowering Drug 1/6/2017
Bay Area's Dynavax (DVAX) Slashes Global Workforce by 38% in Restructuring 1/6/2017
Embattled Theranos Gets a New Landlord 1/6/2017
New Eli Lilly (LLY) CEO's First Move: Shakes Up Leadership Structure in Effort to Recover From Alzheimer's Drug Flop 1/6/2017
Novartis AG (NVS) Athens Offices Raided in Bribery Probe, Exec Threatens With Suicide at Nearby Hotel 1/6/2017
SoCal Biotech Arena (ARNA) Officially Bails on Weight Loss Drug to Focus on New Products 1/5/2017
Alexion (ALXN) Admits Senior Management Pressured Staff to Boost Soliris Sales 1/5/2017
Gilead (GILD) Poaches Cancer R&D Superstar From Novartis AG (NVS) 1/5/2017
How Boston’s Paratek Pharma (PRTK) is Taking Aim at Antibiotic Market and Could Add 85 Jobs 1/5/2017
Infinity Pharma (INFI) Promotes a Handful of Execs, Announces Retirement of R&D Head Effective Jan. 6 1/4/2017
Shire (SHPG) Sells RNA Therapy Program to RaNA Therapeutics for Stake in Company 1/4/2017
As Promised, Allergan (AGN) Unveils Single-Digit Price Hikes for 9 Brand Name Drugs 1/4/2017
New Jersey's Braeburn Pharma Files Paperwork for $150 Million IPO 1/4/2017
1 Bay Area and 1 Massachusetts Biotech That Made Investors Squeal With Glee Last Year 1/4/2017
Top Harvard Scientist Retracts Diabetes Breakthrough Paper 1/4/2017
Chinese Upstart Ascletis Bags $100 Million in Series B Financing 1/4/2017
7 Biotech Stocks to Watch in 2017 1/3/2017
Stem Cell Company Cellular Dynamics Expands and Relocates New Headquarters 1/3/2017
Solid as a Rock, RAUMEDIC Continues U.S. Hiring Spree in 2017 12/30/2016
Innocoll (INNL) Shares Tumble After FDA's Refusal to File Xaracoll NDA 12/30/2016
Like It or Not: Here's How Much Biogen (BIIB)’s Spinraza Will Cost 12/30/2016
Provectus Fires Peter Culpepper as Interim CEO and COO 12/30/2016
Fortress Biotech (FBIO) Surged After Reporting Big Success With CAR-T Cancer Approach 12/30/2016
Investors, Put Your Emotions Aside: There is Hope for Valeant (VRX) in 2017 12/29/2016
Up-and-Coming Tedor Pharma Expands and Adds New Jobs 12/29/2016
FDA Approves First-Ever Treatment for Spinal Muscular Atrophy; Ionis Pharma (IONS), Biogen (BIIB) Seal Victory 12/29/2016
3 Worst Performing Pharma Stocks for 2016 12/29/2016
A Turnaround: Regeneron (REGN) Eyes a Comeback in 2017 12/28/2016
The 7 Worst Clinical Disasters of 2016 12/27/2016
California Biotech ChromaDex, Inc. to Set Up New R&D Plant in Longmont 12/27/2016
Hemostemix to Reorganize; Appoints New Board and Executive Team 12/27/2016
After Fraud Probe, Alexion (ALXN) Reports Failed Soliris Trial 12/27/2016
Tolero Pharmaceuticals to Be Acquired for Up to $780 Million 12/27/2016
Massachusetts Biotech OvaScience (OVAS) Slashes 30% of Workforce; CEO and COO Resign 12/27/2016
Ophthotech (OPHT) Clinical Disaster Spurs Massive Layoffs 12/27/2016
Sinovac Biotech Ltd. (SVA) CEO Reportedly Bribed Chinese FDA, Buyout Offers Could Be in Jeopardy 12/22/2016
This is Why Biogen (BIIB)’s Stock is Set to Soar in 2017 12/22/2016
Roche (RHHBY) Takes a Win as Emicizumab Hemophilia Drug Succeeds in Phase III 12/22/2016
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017 12/22/2016
Acadia (ACAD) Stock Screams Upward; Primary Endpoint Met in Phase II Study of Pimavanserin for Alzheimer’s 12/21/2016
Effective Immediately: Bay Area IMPAX Labs (IPXL) Seeks New CEO 12/21/2016
Why This Biotech Stock Should Be on Everyone's Christmas List 12/21/2016
Meet Biogen (BIIB)'s New CEO 12/21/2016
5 Life Science Stocks Are Breaking Out This Christmas 12/20/2016
An Abandoned Pfizer (PFE) Drug Turns People Into 'Zombies' 12/20/2016
AstraZeneca PLC (AZN) Exec Jumps Ship to Become Innate Pharma (IPH.PA ) CEO 12/20/2016
The 5 Best Biopharma CEOs of 2016 Are... 12/19/2016
White House Kills Plan for Drug Price Cap 12/19/2016
FDA Drops Black Box Warning on Pfizer (PFE)'s Anti-Smoking Drug Chantix 12/19/2016
Wanted: Recipharm AB Seeks New CFO Immediately 12/19/2016
Gilead (GILD) Sinks, Will Pay Rival $2.54 Billion for a Patent Dispute 12/19/2016
Celgene (CELG), Evotec AG (EVTG.F) Ink $295 Million Drug Discovery Pact 12/16/2016
GlaxoSmithKline (GSK)'s New R&D Center to House 450 Scientists and Support Staff, Will Create Up to 200 New Jobs 12/16/2016
And the Trophy for the Worst Biopharma CEO Of 2016 Goes to... 12/16/2016
New York’s Cellectis (ALCLS) Looks to 2017 for Clinical Trials of AML Treatment 12/16/2016
Booming Regeneron (REGN) Buys Another Building in New York 12/16/2016
Flagship Wants a Startup Feel, Changes Name and Creates $285 Million 'Special Opportunities' Fund 12/15/2016
Ackman Drops Some Valeant (VRX) Shares, Papa Blames Media for Plummeting Share Prices 12/15/2016
INC Research (INCR) Creating 550 New Jobs in HQ Move 12/14/2016
Siemens Healthineers (SI)' $300 Million Expansion to Create Up to 700 New Jobs in Massachusetts 12/14/2016
Bay Area's Harpoon Therapeutics Taps Former Kolltan Pharma Exec as New CEO 12/14/2016
This Man Could be Trump's Frontrunner for Top FDA Job 12/14/2016
Look Who Just Joined Embattled Theranos' Roster 12/14/2016
Top 3 Most Profitable Companies in Biotech 12/14/2016
New York Bets $650 Million to Spark a Biotech Boom 12/13/2016
Alexion (ALXN) CEO and CFO Abruptly Step Down, Former AstraZeneca PLC (AZN) CEO Named New Leader 12/13/2016
A Look Into BioMarin (BMRN)'s Spanking New R&D Center 12/13/2016



//-->